David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Stepan Co
SCL
$1.41B
| $440K | ﹤0.01% |
4,653
-43,035
| -90% | -$3.44M |
|
|
UHGWW
3427
DELISTED
United Homes Group Warrant
UHGWW
| $440K | ﹤0.01% |
439,789
| – | – |
|
|
GMS
3428
DELISTED
GMS Inc
GMS
| $439K | ﹤0.01% |
5,325
-64,149
| -92% | -$4.3M |
|
3429
CALL
Intuitive Surgical
ISRG
$131B
| $439K | ﹤0.01% |
1,300
-20,700
| -94% | -$6.17M |
|
3430
VanEck Morningstar Wide Moat ETF
MOAT
$12.4B
| $437K | ﹤0.01% |
+5,145
| New | +$400K |
|
3431
RUM Group Inc
RUM
$5.03B
| $437K | ﹤0.01% |
97,268
+79,029
| +433% | +$386K |
|
|
TRST
3432
Trustco Bank Corp NY
TRST
$977M
| $436K | ﹤0.01% |
14,034
-5,845
| -29% | -$163K |
|
3433
PUT
Nucor
NUE
$55.9B
| $435K | ﹤0.01% |
2,500
-1,100
| -31% | -$174K |
|
|
AVPTW
3434
DELISTED
AvePoint Inc Warrant
AVPTW
| $435K | ﹤0.01% |
330,794
| – | – |
|
|
RJET
3435
Republic Airways Holdings
RJET
$878M
| $434K | ﹤0.01% |
28,620
-5,546
| -16% | -$65.9K |
|
3436
Atlanta Braves Holdings Series A
BATRA
$3.66B
| $432K | ﹤0.01% |
10,106
-112
| -1% | -$4.49K |
|
|
TARO
3437
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $432K | ﹤0.01% |
10,345
+367
| +4% | +$13.5K |
|
|
OTLY
3438
Oatly Group
OTLY
$509M
| $431K | ﹤0.01% |
18,270
+17,207
| +1,619% | +$284K |
|
3439
CALL
IonQ
IONQ
$17.1B
| $431K | ﹤0.01% |
34,800
+15,600
| +81% | +$201K |
|
3440
CALL
PBF Energy
PBF
$8.1B
| $431K | ﹤0.01% |
9,800
| – | – |
|
|
SII
3441
Sprott
SII
$3.54B
| $430K | ﹤0.01% |
12,700
-12,000
| -49% | -$371K |
|
3442
Factset
FDS
$10.7B
| $429K | ﹤0.01% |
900
-708
| -44% | -$319K |
|
3443
Crocs
CROX
$5.8B
| $429K | ﹤0.01% |
+4,593
| New | +$424K |
|
|
SPNS
3444
DELISTED
Sapiens International
SPNS
| $427K | ﹤0.01% |
14,759
-22,499
| -60% | -$598K |
|
|
AMED
3445
DELISTED
Amedisys
AMED
| $427K | ﹤0.01% |
4,492
-10,881
| -71% | -$1.02M |
|
3446
Sasol
SSL
$7.38B
| $425K | ﹤0.01% |
42,774
-39,932
| -48% | -$470K |
|
3447
Coherus Oncology
CHRS
$215M
| $425K | ﹤0.01% |
127,610
-578,798
| -82% | -$1.55M |
|
|
CHCT
3448
Community Healthcare Trust
CHCT
$426M
| $425K | ﹤0.01% |
15,941
+3,723
| +30% | +$103K |
|
3449
Corning
GLW
$128B
| $422K | ﹤0.01% |
13,860
-11,380
| -45% | -$325K |
|
3450
FirstEnergy
FE
$27B
| $420K | ﹤0.01% |
11,470
-6,278
| -35% | -$227K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.